---
schema_version: "secwatch.filing_event.v1"
accession: "0001567264-25-000071"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:26:53.586669+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics raises $6.6M via ATM stock sales; cash runway extended to H2 2026

## Summary
- Gross proceeds of $6.6M ($6.3M net) from sale of 19,868,658 shares at avg $0.3323/share in July 2025.
- Shares outstanding post-ATM: 46,035,081 as of July 31, 2025.
- Average price per share >10% higher than June 2025 public offering, reducing dilution cost.
- Proceeds extend cash runway into second half of 2026 to advance clinical trials.

## SEC filing metadata
- accession: 0001567264-25-000071
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000156726425000071/0001567264-25-000071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000156726425000071/intensity-20250804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001567264-25-000071
- JSON: https://secwatch.observer/filing/0001567264-25-000071.json
- Plain text: https://secwatch.observer/filing/0001567264-25-000071.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.